arrow
E

Elizabeth R. Tucker

royal marsden nhs foundation trust
H指数:12
被引数:523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2023-01-0513
OAAI
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

ALK信号通路中的突变赋予对ALK抑制剂治疗的抗性,导致神经母细胞瘤细胞的附带脆弱性

2022-06-1026
OAAI
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

加速神经母细胞瘤的药物开发-新药开发战略: 儿童癌症的创新疗法,欧洲儿童和青少年癌症研究网络和国际儿科肿瘤学会欧洲神经母细胞瘤项目

2017-06-2640
OAAI